Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 2Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 226Lymphoma 221Lymphoma, Non-Hodgkin 194Leukemia, Lymphocytic, Chronic, B-Cell 175Lymphoma, Large B-Cell, Diffuse 170Lymphoma, Follicular 164Lymphoma, B-Cell 108Lymphoma, Mantle-Cell 102Hodgkin Disease 99Recurrence 94Leukemia, Myeloid, Acute 94Multiple Myeloma 89Burkitt Lymphoma 86Leukemia 76Neoplasms 66Hematologic Neoplasms 58Lymphoma, B-Cell, Marginal Zone 56Myelodysplastic Syndromes 52Waldenstrom Macroglobulinemia 42Lymphoma, T-Cell 42Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 37Lymphoma, T-Cell, Peripheral 35Lymphoma, T-Cell, Cutaneous 31Leukemia, Biphenotypic, Acute 28Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27Leukemia, B-Cell 27Mycosis Fungoides 25Lymphoma, Large-Cell, Anaplastic 25Sarcoma 24Lymphoproliferative Disorders 20

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Philadelphia Chromosome × Lymphoid × 90 days × Clear all
NCT05442515 2026-05-28

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting
130 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Philadelphia Chromosome, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡